Copyright Reports & Markets. All rights reserved.

Global Preterm Birth Prevention and Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Preterm Birth Prevention and Treatment Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Progesterone Therapy
    • 1.4.3 Corticosteroid Therapy
    • 1.4.4 Tocolytics Therapy
    • 1.4.5 Antihypertensive Therapy
    • 1.4.6 Magnesium Sulfate Therapy
    • 1.4.7 Other
  • 1.5 Market by Application
    • 1.5.1 Global Preterm Birth Prevention and Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Drugs Stores
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Preterm Birth Prevention and Treatment Market Perspective (2015-2026)
  • 2.2 Preterm Birth Prevention and Treatment Growth Trends by Regions
    • 2.2.1 Preterm Birth Prevention and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Preterm Birth Prevention and Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Preterm Birth Prevention and Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Preterm Birth Prevention and Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Preterm Birth Prevention and Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Preterm Birth Prevention and Treatment Players by Market Size
    • 3.1.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Preterm Birth Prevention and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Preterm Birth Prevention and Treatment Market Concentration Ratio
    • 3.2.1 Global Preterm Birth Prevention and Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Preterm Birth Prevention and Treatment Revenue in 2019
  • 3.3 Preterm Birth Prevention and Treatment Key Players Head office and Area Served
  • 3.4 Key Players Preterm Birth Prevention and Treatment Product Solution and Service
  • 3.5 Date of Enter into Preterm Birth Prevention and Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2021-2026)

5 Preterm Birth Prevention and Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)
  • 5.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Preterm Birth Prevention and Treatment Market Size (2015-2020)
  • 6.2 Preterm Birth Prevention and Treatment Key Players in North America (2019-2020)
  • 6.3 North America Preterm Birth Prevention and Treatment Market Size by Type (2015-2020)
  • 6.4 North America Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Preterm Birth Prevention and Treatment Market Size (2015-2020)
  • 7.2 Preterm Birth Prevention and Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Preterm Birth Prevention and Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Preterm Birth Prevention and Treatment Market Size (2015-2020)
  • 8.2 Preterm Birth Prevention and Treatment Key Players in China (2019-2020)
  • 8.3 China Preterm Birth Prevention and Treatment Market Size by Type (2015-2020)
  • 8.4 China Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Preterm Birth Prevention and Treatment Market Size (2015-2020)
  • 9.2 Preterm Birth Prevention and Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Preterm Birth Prevention and Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Preterm Birth Prevention and Treatment Market Size (2015-2020)
  • 10.2 Preterm Birth Prevention and Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Preterm Birth Prevention and Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Preterm Birth Prevention and Treatment Market Size (2015-2020)
  • 11.2 Preterm Birth Prevention and Treatment Key Players in India (2019-2020)
  • 11.3 India Preterm Birth Prevention and Treatment Market Size by Type (2015-2020)
  • 11.4 India Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Preterm Birth Prevention and Treatment Market Size (2015-2020)
  • 12.2 Preterm Birth Prevention and Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Preterm Birth Prevention and Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Preterm Birth Prevention and Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AMAG Pharmaceuticals
    • 13.1.1 AMAG Pharmaceuticals Company Details
    • 13.1.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
    • 13.1.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Introduction
    • 13.1.4 AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2015-2020))
    • 13.1.5 AMAG Pharmaceuticals Recent Development
  • 13.2 Ferring Pharmaceutical
    • 13.2.1 Ferring Pharmaceutical Company Details
    • 13.2.2 Ferring Pharmaceutical Business Overview and Its Total Revenue
    • 13.2.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Introduction
    • 13.2.4 Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.2.5 Ferring Pharmaceutical Recent Development
  • 13.3 Teva
    • 13.3.1 Teva Company Details
    • 13.3.2 Teva Business Overview and Its Total Revenue
    • 13.3.3 Teva Preterm Birth Prevention and Treatment Introduction
    • 13.3.4 Teva Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.3.5 Teva Recent Development
  • 13.4 Allergan
    • 13.4.1 Allergan Company Details
    • 13.4.2 Allergan Business Overview and Its Total Revenue
    • 13.4.3 Allergan Preterm Birth Prevention and Treatment Introduction
    • 13.4.4 Allergan Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.4.5 Allergan Recent Development
  • 13.5 AbbVie
    • 13.5.1 AbbVie Company Details
    • 13.5.2 AbbVie Business Overview and Its Total Revenue
    • 13.5.3 AbbVie Preterm Birth Prevention and Treatment Introduction
    • 13.5.4 AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.5.5 AbbVie Recent Development
  • 13.6 Aurobindo Pharma
    • 13.6.1 Aurobindo Pharma Company Details
    • 13.6.2 Aurobindo Pharma Business Overview and Its Total Revenue
    • 13.6.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Introduction
    • 13.6.4 Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.6.5 Aurobindo Pharma Recent Development
  • 13.7 Bayer
    • 13.7.1 Bayer Company Details
    • 13.7.2 Bayer Business Overview and Its Total Revenue
    • 13.7.3 Bayer Preterm Birth Prevention and Treatment Introduction
    • 13.7.4 Bayer Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.7.5 Bayer Recent Development
  • 13.8 Mylan
    • 13.8.1 Mylan Company Details
    • 13.8.2 Mylan Business Overview and Its Total Revenue
    • 13.8.3 Mylan Preterm Birth Prevention and Treatment Introduction
    • 13.8.4 Mylan Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.8.5 Mylan Recent Development
  • 13.9 Pfizer
    • 13.9.1 Pfizer Company Details
    • 13.9.2 Pfizer Business Overview and Its Total Revenue
    • 13.9.3 Pfizer Preterm Birth Prevention and Treatment Introduction
    • 13.9.4 Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.9.5 Pfizer Recent Development
  • 13.10 Merck & Co
    • 13.10.1 Merck & Co Company Details
    • 13.10.2 Merck & Co Business Overview and Its Total Revenue
    • 13.10.3 Merck & Co Preterm Birth Prevention and Treatment Introduction
    • 13.10.4 Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 13.10.5 Merck & Co Recent Development
  • 13.11 Novartis
    • 10.11.1 Novartis Company Details
    • 10.11.2 Novartis Business Overview and Its Total Revenue
    • 10.11.3 Novartis Preterm Birth Prevention and Treatment Introduction
    • 10.11.4 Novartis Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 10.11.5 Novartis Recent Development
  • 13.12 Sanofi
    • 10.12.1 Sanofi Company Details
    • 10.12.2 Sanofi Business Overview and Its Total Revenue
    • 10.12.3 Sanofi Preterm Birth Prevention and Treatment Introduction
    • 10.12.4 Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2015-2020)
    • 10.12.5 Sanofi Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Preterm Birth Prevention and Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Preterm Birth Prevention and Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    AMAG Pharmaceuticals
    Ferring Pharmaceutical
    Teva
    Allergan
    AbbVie
    Aurobindo Pharma
    Bayer
    Mylan
    Pfizer
    Merck & Co
    Novartis
    Sanofi

    Market segment by Type, the product can be split into
    Progesterone Therapy
    Corticosteroid Therapy
    Tocolytics Therapy
    Antihypertensive Therapy
    Magnesium Sulfate Therapy
    Other
    Market segment by Application, split into
    Hospital
    Drugs Stores
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Preterm Birth Prevention and Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Preterm Birth Prevention and Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Preterm Birth Prevention and Treatment are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now